Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)-Reference-Cited by-同舟云学术

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)

Published:2014-01-02 Issue:1 Volume:123 Page:78-85
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Dhodapkar Madhav V.¹,Sexton Rachael²,Waheed Sarah³,Usmani Saad³,Papanikolaou Xenofon³,Nair Bijay³,Petty Nathan³,Shaughnessy John D.³,Hoering Antje²,Crowley John²,Orlowski Robert Z.⁴,Barlogie Bart³

Affiliation:

1. Yale Cancer Center, Yale University, New Haven, CT;

2. SWOG Statistical Center/Cancer Research and Biostatistics, Seattle, WA;

3. Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; and

4. University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Key Points First prospective US cooperative trial group in preneoplastic gammopathies. Prospective demonstration that genomic features of preneoplastic cells predict disease risk.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/1/78/1373947/78.pdf

Reference43 articles.

1. Multiple myeloma.;Palumbo;N Engl J Med,2011

2. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.;Landgren;Blood,2009

3. A monoclonal gammopathy precedes multiple myeloma in most patients.;Weiss;Blood,2009

4. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.;International Myeloma Working Group;Br J Haematol,2003

5. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.;Kyle;N Engl J Med,2007

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CT;Die Radiologie;2024-07-17

2. Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions;Pharmaceuticals;2024-07-06

3. Still high risk? A review of translocation t(14;16) in multiple myeloma;American Journal of Hematology;2024-06-14

4. Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens;Journal of Translational Medicine;2024-06-07

5. Impact of Clonal Heterogeneity in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04